• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

Who did Ramona Fire?









I'm TAP legacy and I'm sooooooo happy that both Patnoe and Wilson were cut. I was around when Wilson gutted the managed markets team of all TAP legacy people and Patnoe just sat there and allowed him to do it. I can't believe we didn't have any reprocussions on that one. And after the TAP RAM's were cut, what type of managed care support did we get. We got crap from RAM's that were aloof and coddled. That was the beginning of the downward slide for this company. I'm hoping these firings can help us get back on track as a company.

It's the first time in a long time me a little rank and file manager has agreed with firing decisions in a long long time. Good job. Let's right this ship!!
Too little,too late,to return Takeda to the ethical,respected company it once was.That ship has sailed,and now Takeda aimlessly just drifting alon,trying to see what other "me-too"products they can bring to market!